Prosecution Insights
Last updated: October 25, 2026

Schott Pharma AG & Co. Kgaa

Technology areas: Chemistry & Materials • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering

5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Schott Pharma AG & Co. Kgaa manages a patent portfolio within the Chemistry & Materials technology area. The company currently has 5 pending office actions. These 5 pending office actions are distributed among 5 distinct examiners. This distribution indicates that each active matter is being reviewed by a different individual at the patent office. Practitioners should prepare for different sets of examiner preferences and communication styles based on this arrangement.

The portfolio is active across 5 distinct art units. This involvement in 5 distinct art units shows that the company's technical subject matter is evaluated by multiple specialized groups. KIRSCH, ANDREW THOMAS is the busiest examiner for this portfolio, currently overseeing 1 pending office action. Because this examiner only handles a single case, the influence of KIRSCH, ANDREW THOMAS is limited to one part of the current portfolio.

The 5 pending office actions represent the current workload that must be managed across different technical divisions. The role of KIRSCH, ANDREW THOMAS is one of several separate examiner interactions. This distribution across 5 distinct art units suggests that the company's innovations intersect with various technical classifications. The 5 distinct examiners ensure that the prosecution strategy remains decentralized across the USPTO.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

5
Total Pending OAs
3
Non-Final OAs
1
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (80%)
1
Medium (20%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (20%)
Multi-statute (no §101)4 (80%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
60% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
40% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KIRSCH, ANDREW THOMAS 1 50.6% +34.6%
KOSKY, JUSTIN THOMAS 1 — —
DEHGHAN, QUEENIE S 1 62.4% +10.7%
TALBERT, ERIC MICHAEL 1 22.2% +55.6%
MIGGINS, MICHAEL C 1 80.8% +16.6%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18471763 PHARMACEUTICAL CONTAINER MIGGINS, MICHAEL C 9d
18885863 Hot forming tool for glass bottle necks DEHGHAN, QUEENIE S 29d
19214884 GLASS CONTAINERS FOR PACKAGING SALT OR SUGAR-CONTAINING COMPOSITIONS IN A FROZEN STATE KIRSCH, ANDREW THOMAS —
19172874 NON-CONTACT PROCESSING OF FORMED CARTRIDGES KOSKY, JUSTIN THOMAS —
18739962 Process and device for steam sterilization of primary packaging means TALBERT, ERIC MICHAEL —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18471763 PHARMACEUTICAL CONTAINER MIGGINS, MICHAEL C 9d
18885863 Hot forming tool for glass bottle necks DEHGHAN, QUEENIE S 29d
19214884 GLASS CONTAINERS FOR PACKAGING SALT OR SUGAR-CONTAINING COMPOSITIONS IN A FROZEN STATE KIRSCH, ANDREW THOMAS —
18739962 Process and device for steam sterilization of primary packaging means TALBERT, ERIC MICHAEL —

Top Art Units

Art UnitApps
3733 1
3655 1
1741 1
1758 1
1782 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19214884 GLASS CONTAINERS FOR PACKAGING SALT OR SUGAR-CONTAINING COMPOSITIONS IN A FROZEN STATE KIRSCH, ANDREW THOMAS 3733 §103§112 Non-Final OA — Pending May 21, 2025
19172874 NON-CONTACT PROCESSING OF FORMED CARTRIDGES KOSKY, JUSTIN THOMAS 3655 §102§103§112 Non-Final OA — Pending Apr 08, 2025
18885863 Hot forming tool for glass bottle necks DEHGHAN, QUEENIE S 1741 §102§103§112 Final Rejection 29d Pending Sep 16, 2024
18739962 Process and device for steam sterilization of primary packaging means TALBERT, ERIC MICHAEL 1758 §103§112DP Non-Final OA — Pending Jun 11, 2024
18471763 PHARMACEUTICAL CONTAINER MIGGINS, MICHAEL C 1782 §102§103 Non-Final OA 9d Pending Sep 21, 2023

Managing Schott Pharma AG & Co. Kgaa's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Schott Pharma AG & Co. Kgaa have?

Schott Pharma AG & Co. Kgaa has 5 pending office actions as of October 2026, spread across 5 art units and 5 examiners.

Which USPTO examiner handles the most Schott Pharma AG & Co. Kgaa applications?

Andrew Thomas Kirsch has the most, with 1 of Schott Pharma AG & Co. Kgaa's pending office actions.

What technology area are Schott Pharma AG & Co. Kgaa's patent applications in?

Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month